Search and Discover China Trade Knowledge from Trusted Sources™
Current Language: English
Popular Search Results
Contact / Blog
Email / RSS
Search this Author
Sansheng Pharmaceutical sati...
China's private enterprises listed in the United States in recent years has become so rampant. In order to achieve the purpose of listing and financing, an endless stream of innovative methods of ...
Novartis governance suspecte...
As a result of the treatment of constipation Novartis drug Zelnorm (Malay Tegaserod) may lead to cardiovascular disease, the U.S. Food and Drug Administration (FDA) requirements, Novartis will b...
Eli Lilly first quarter prof...
April 16, 2007, the U.S. pharmaceutical company Eli Lilly (NYSE: LLY) announced first quarter 2007 earnings report, profit for the 913.3 million U.S. dollars or 0.84 U.S. dollars / share, exceedin...
The world's best-selling an...
Eli Lilly Company and the German company Boehringer Ingelheim on the 14th held a press conference here, announced a joint marketing in the global scope of the latest antidepressants Baida-yan, an of...
2006 France OTC market to re...
According to IMS statistics, in 2006 France OTC market has reached 1.8 billion euros (about 2.3 billion U.S. dollars), France OTC market in 2006 grew by 8.8 percent, representing a 3 percent decli...
Brazil alleged monopoly Roch...
A few days ago from the Chinese Embassy in Brazil was informed, Brazil protection of economic management committee has announced that as a result of Roche (ROCHE), BASF (BASF) and Sanofi-Aventis...
The international pharmaceut...
With the pharmaceutical market in emerging countries showing a booming trend in these areas will become a transnational pharmaceutical company's future park. The article said that with the expans...
The financing of Chinese ent...
For Chinese enterprises, in order to "drugs" in his capacity as the legally enter the U.S. market, has always been a lot of Chinese medicine enterprise. "First Financial Daily" has recently (Apri...
British AstraZeneca MedImmun...
April 23, the United Kingdom AstraZeneca (AstraZeneca), said it plans to acquire U.S. biotechnology company MedImmune. It is understood that AstraZeneca will be 58 U.S. dollars per share price o...
Wyeth will enter the Chinese...
In China with a well-known Wyeth milk powder (China) Co., Ltd., said yesterday that Wyeth plans to second quarter of next year in China's listed early childhood pneumococcal vaccine (Prevena), ...
Designated brands and trademarks are property of their respective owners. Use of this website constitutes acceptance of SourceJuice.com
Copyright © 2007 - 2009 SourceJuice.com & SourceJuice All Rights Reserved.